Go to content Go to navigation

Clinical Results for ProACT™

Clinical Results for Patients with Post-Prostatectomy Incontinence

ProACT Therapy has been proven effective for post-prostatectomy incontinence. During a previous study, participants reported using fewer pads [Figure 1] and experiencing a greater quality of life after ProACT Device implant. Before the implant, almost 70% of patients used at least four pads per day, and more than 30% used 1-3 pads per day. Two years after the implant, 35% of patients used no pads at all, 45% used only one pad (often for security), 10% used 2-3 pads and 10% of the patients used at least four pads.1 These results are also supported by other reported studies.2,3,4

Figure 1. Pad Usage After ProACT Implant

Figure: Pad usage after ProACT implant

The potential risks with the ProACT implant procedure are similar to those for other surgical treatments for stress urinary incontinence. These include, but are not limited to, the following:

  • Tissue perforation (tear)
  • Device migration
  • Post-operative urgency, frequency or retention
  • Tissue erosion/infection at the implant site
  • Device failure
  • Non-response to treatment

If an infection occurs at the implant site, it can be treated with antibiotics. If the device migrates, minor changes can be made to improve the positioning. If the patient goes into retention (inability to pass urine), balloon volume can be reduced to eliminate this issue. If a more serious side effect occurs (e.g., perforation, migration), ProACT can be completely removed. Please ask your doctor any questions you may have about the procedure.

Important Safety Information About ProACT

Contact Uromedica Contact Uromedica to learn more about how ProACT Therapy may meet your individual needs.

Footnotes

1 Hübner WA, Schlarp OM. Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy. Br J Urol. Sep 2005:96(4);587-94.

2 “Treatments of Incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy” by Hübner W and Schlarp O in BJUI Sep 2005 96 (4), 587-594.

3 “Prospective Study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for Post Radical Prostatectomy Incontinence” by Trigo Rocha F et.al. in Urology 67 (5) 2006 965-969.

4 “Adjustable Continence Therapy for the treatment of male stress urinary incontinence: a single-centre study” by Kocjancic E in Scand. Jrnl of Urolo. And Nephr. 2007; 41:324-328.

—This page last modified Wednesday February 6, 2008